These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 21529736

  • 1. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator.
    Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA.
    Am J Cardiol; 2011 Jul 01; 108(1):69-74. PubMed ID: 21529736
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
    Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT.
    Europace; 2008 May 01; 10(5):545-51. PubMed ID: 18378633
    [Abstract] [Full Text] [Related]

  • 4. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA.
    Am Heart J; 2005 Apr 01; 149(4):664-9. PubMed ID: 15990750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May 01; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

  • 10. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
    Pedersen SS, Theuns DA, Jordaens L, Kupper N.
    Europace; 2010 Aug 01; 12(8):1119-26. PubMed ID: 20507853
    [Abstract] [Full Text] [Related]

  • 11. Effect of depression on mortality in implantable cardioverter defibrillator recipients--findings from the prospective LICAD study.
    Tzeis S, Kolb C, Baumert J, Reents T, Zrenner B, Deisenhofer I, Ronel J, Andrikopoulos G, Ladwig KH.
    Pacing Clin Electrophysiol; 2011 Aug 01; 34(8):991-7. PubMed ID: 21438895
    [Abstract] [Full Text] [Related]

  • 12. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality.
    Pedersen SS, VAN DEN Berg M, Erdman RA, VAN Son J, Jordaens L, Theuns DA.
    Pacing Clin Electrophysiol; 2009 Feb 01; 32(2):184-92. PubMed ID: 19170907
    [Abstract] [Full Text] [Related]

  • 13. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study.
    Pedersen SS, den Broek KC, Theuns DA, Erdman RA, Alings M, Meijer A, Jordaens L, Denollet J.
    Int J Cardiol; 2011 Mar 17; 147(3):420-3. PubMed ID: 19896732
    [Abstract] [Full Text] [Related]

  • 14. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.
    Habibović M, Versteeg H, Pelle AJ, Theuns DA, Jordaens L, Pedersen SS.
    Europace; 2013 Mar 17; 15(3):355-61. PubMed ID: 22989939
    [Abstract] [Full Text] [Related]

  • 15. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C.
    Arch Gen Psychiatry; 2008 Nov 17; 65(11):1324-30. PubMed ID: 18981344
    [Abstract] [Full Text] [Related]

  • 16. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
    Hoogwegt MT, Kupper N, Theuns DA, Jordaens L, Pedersen SS.
    Europace; 2012 Jan 17; 14(1):74-80. PubMed ID: 21920910
    [Abstract] [Full Text] [Related]

  • 17. Increased emotional distress in type-D cardiac patients without a partner.
    van den Broek KC, Martens EJ, Nyklícek I, van der Voort PH, Pedersen SS.
    J Psychosom Res; 2007 Jul 17; 63(1):41-9. PubMed ID: 17586336
    [Abstract] [Full Text] [Related]

  • 18. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
    Hoogwegt MT, Kupper N, Jordaens L, Pedersen SS, Theuns DA.
    Europace; 2013 Oct 17; 15(10):1468-74. PubMed ID: 23608028
    [Abstract] [Full Text] [Related]

  • 19. The distressed (Type D) personality in both patients and partners enhances the risk of emotional distress in patients with an implantable cardioverter defibrillator.
    van den Broek KC, Versteeg H, Erdman RA, Pedersen SS.
    J Affect Disord; 2011 May 17; 130(3):447-53. PubMed ID: 21093061
    [Abstract] [Full Text] [Related]

  • 20. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.
    Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L.
    Europace; 2007 Aug 17; 9(8):675-80. PubMed ID: 17434891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.